KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Current Taxes (2021 - 2023)

Historic Current Taxes for Vir Biotechnology (VIR) over the last 3 years, with Q1 2023 value amounting to $15.3 million.

  • Vir Biotechnology's Current Taxes fell 9622.85% to $15.3 million in Q1 2023 from the same period last year, while for Mar 2023 it was $15.3 million, marking a year-over-year decrease of 9622.85%. This contributed to the annual value of $15.2 million for FY2022, which is 14494.13% up from last year.
  • According to the latest figures from Q1 2023, Vir Biotechnology's Current Taxes is $15.3 million, which was down 9622.85% from $15.2 million recorded in Q4 2022.
  • Over the past 5 years, Vir Biotechnology's Current Taxes peaked at $404.4 million during Q1 2022, and registered a low of $6.2 million during Q4 2021.
  • Over the past 3 years, Vir Biotechnology's median Current Taxes value was $56.7 million (recorded in 2022), while the average stood at $116.1 million.
  • Its Current Taxes has fluctuated over the past 5 years, first surged by 14494.13% in 2022, then plummeted by 9622.85% in 2023.
  • Quarter analysis of 3 years shows Vir Biotechnology's Current Taxes stood at $6.2 million in 2021, then skyrocketed by 144.94% to $15.2 million in 2022, then increased by 0.16% to $15.3 million in 2023.
  • Its last three reported values are $15.3 million in Q1 2023, $15.2 million for Q4 2022, and $98.2 million during Q3 2022.